MediciNova

$5.32
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.27 (-4.83%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can buy or sell MediciNova and other stocks, options, and ETFs commission-free!

About MNOV

Medicinova Inc Common Stock, also called MediciNova, is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs. Its development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA. The listed name for MNOV is Medicinova Inc Common Stock.

CEO
Yuichi Iwaki
Employees
9
Headquarters
La Jolla, California
Founded
2000
Market Cap
253.53M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
132.95K
High Today
$5.64
Low Today
$5.30
Open Price
$5.60
Volume
167.10K
52 Week High
$13.25
52 Week Low
$2.79

MNOV Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 16, After Hours

You May Also Like

KRP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure